Ascendis Pharma A-S
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $158,045 | $100,954 | $173,916 | $57,833 |
Gross Profit | 126,598 | 83,437 | 159,893 | 46,632 |
EBITDA | 2,319 | -44,234 | -37,893 | -71,129 |
EBIT | -1,989 | -48,779 | -42,368 | -72,831 |
Net Income | -38,855 | -94,626 | -38,469 | -99,198 |
Net Change In Cash | 158,045 | 100,954 | 173,916 | 57,833 |
Free Cash Flow | -11,679 | -15,016 | -87,559 | -56,634 |
Cash | 494,046 | 517,923 | 559,543 | 625,515 |
Basic Shares | 63,911 | 60,018 | 59,785 | 58,565 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $363,641 | $266,718 | $51,174 | $7,778 |
Gross Profit | 319,383 | 222,323 | 39,037 | 4,255 |
EBITDA | -290,023 | -411,168 | -529,177 | -364,642 |
EBIT | -307,737 | -430,079 | -546,691 | -380,033 |
Net Income | -378,084 | -481,447 | -583,194 | -383,577 |
Net Change In Cash | 363,641 | 266,718 | 51,174 | 7,778 |
Free Cash Flow | -307,624 | -469,803 | -510,188 | -441,883 |
Cash | 559,543 | 392,164 | 444,767 | 446,267 |
Basic Shares | 57,891 | 56,287 | 56,071 | 54,771 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.64 |
2025-03-31 | -$1.58 |
2024-12-31 | -$0.64 |
